Westpac has followed ASIC’s lead, launching a separate appeal to a ruling that it provided financial advice but not personal advice as part of a campaign encouraging customers to roll over external superannuation accounts.
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.
A former managing director at global foreign exchange giant Travelex has filed a lawsuit against his former employer, seeking over $1.3 million in compensation and damages.
A senior female partner at Piper Alderman will go into mediation this week with representatives of the firm’s partnership to try to resolve her sex discrimination lawsuit, which alleges a group of equity partners have used baseless complaints of bullying to try to push her out.
GetSwift has warned it may seek an injunction blocking Johnson Winter & Slattery from acting as instructing lawyers to the corporate cop in its enforcement action against the logistics company, saying the firm provided advisory work for it last year.
Maurice Blackburn has lost a long-running fight with the Australian Taxation Office over a tax bill on two massive class action settlements secured by the firm for thousands of Black Saturday bushfire victims.
An appeal by federal Minister for Jobs Kelly O’Dwyer for review of a decision approving an enterprise agreement she clams unlawfully discriminates against female firefighters by restricting employees from working part time could, if successful, be revolutionary, the Fair Work Commission said Wednesday.
A litigation funder wants the High Court to review a court decision’s to approve a $64 million settlement in litigation over the failure of Banksia Securities while rejecting the funder’s commission and legal fees.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly “inconsistent” pleadings.
A judge has rejected a bid by Bellamy’s to limit the recoverable costs of rival law firms running joint class actions against the baby food maker, saying he would deal with any unjustified duplication later, not now.